Streptozotocin-induced diabetes in rats modifies the role D 2 , D 3 and D 4 dopamine receptors play in cardiac sympathetic inhibition.

Published in: Basic & clinical pharmacology & toxicology (2022)

receptor subtypes could be a novel drug target for the therapy of typical cardiac complications of diabetes.

Keyphrases